Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-Xun Lu

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Therapeutic Advances in Gastroenterology|October 21, 2017
Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinomaShao-Hang Cai, Shi-Xun Lu, Li-Li Liu, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2010
The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective studyRong-Xin Zhang, Xiao-Jun Wu, Shi-Xun Lu, et al.
American Journal of Cancer Research|July 16, 2015
Decrease of Bcl-xL/Bcl-2-associated death promoter in hepatocellular carcinoma indicates poor prognosisWen Hu, Jia Fu, Shi-Xun Lu, et al.
Translational Oncology|December 18, 2017
eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular CarcinomaShi-Lu Chen, Shi-Xun Lu, Li-Li Liu, et al.
Scientific Reports|November 24, 2017
Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patientsRong-Xin Zhang, Zhong-Guo Zhou, Shi-Xun Lu, et al.
Molecular Oncology|November 1, 2019
Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathwaysShi-Lu Chen, Li-Li Liu, Chun-Hua Wang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 24, 2023
The relationship between brain metastasis and HER2 expression status in gastric cancerMing-Yu Lai, Wen-Long Guan, Jing Yang, et al.
Oncotarget|March 20, 2015
Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinomaWen Hu, Shi-Xun Lu, Min Li, et al.
Cancer Letters|June 5, 2017
Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinomaShi-Xun Lu, Chris Zhiyi Zhang, Rong-Zhen Luo, et al.
Oncotarget|June 28, 2014
FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2Li-Li Liu, Shi-Xun Lu, Min Li, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Gastroenterology|October 21, 2017
Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinomaShao-Hang Cai, Shi-Xun Lu, Li-Li Liu, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2010
The effect of COX-2 inhibitor on capecitabine-induced hand-foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective studyRong-Xin Zhang, Xiao-Jun Wu, Shi-Xun Lu, et al.
American Journal of Cancer Research|July 16, 2015
Decrease of Bcl-xL/Bcl-2-associated death promoter in hepatocellular carcinoma indicates poor prognosisWen Hu, Jia Fu, Shi-Xun Lu, et al.
Translational Oncology|December 18, 2017
eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular CarcinomaShi-Lu Chen, Shi-Xun Lu, Li-Li Liu, et al.
Scientific Reports|November 24, 2017
Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patientsRong-Xin Zhang, Zhong-Guo Zhou, Shi-Xun Lu, et al.
Molecular Oncology|November 1, 2019
Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathwaysShi-Lu Chen, Li-Li Liu, Chun-Hua Wang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 24, 2023
The relationship between brain metastasis and HER2 expression status in gastric cancerMing-Yu Lai, Wen-Long Guan, Jing Yang, et al.
Oncotarget|March 20, 2015
Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinomaWen Hu, Shi-Xun Lu, Min Li, et al.
Cancer Letters|June 5, 2017
Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinomaShi-Xun Lu, Chris Zhiyi Zhang, Rong-Zhen Luo, et al.
Oncotarget|June 28, 2014
FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2Li-Li Liu, Shi-Xun Lu, Min Li, et al.
Pageof 4